Two second-site mutations in Moloney murine leukemia virus envelope surface protein (SU) were previously shown to rescue infection of two different SU mutants, a fusion-defective point mutant and a fusion-defective modified SU that exhibits weak subunit association. We report here that they also rescue infection of a third defective SU, one modified by insertion of the green fluorescent protein (GFP) between serine 6 and proline 7. GFP-SU assembled into virions and showed a strong association with the transmembrane protein (TM). However, these virions were noninfectious. GFP-SU expression was not maintained within cells, suggesting that the protein was toxic. Addition of the second-site mutations rendered the GFP-SU virus infectious and resulted in prolonged expression of the modified envelope protein. This virus showed a slight reduction in receptor binding but not in envelope protein processing, suggesting that addition of the GFP sequences results in subtle structural changes. Extrapolating these data, we see that the fundamental problem with the GFP-SU envelope protein appears to be a folding problem, suggesting that the second-site mutations rescue GFP-SU primarily by a mechanism that involves stabilizing the envelope protein structure.Deletion or replacement of the essential histidine at position 8 of the ecotropic Moloney murine leukemia virus (MoMLV) surface protein (SU) results in loss of infection. Histidine 8 mutants maintain a stable association with the transmembrane protein (TM) and bind to the ecotropic receptor but fail to mediate virus-cell fusion (2, 17). Fusion and infection can be rescued by adding two second-site amino acid changes: a glutamine-to-arginine change at position 227 (Q227R) and an aspartate-to-tyrosine change at position 243 (D243Y) (17).These second-site mutations also rescue the phenotype of another defective envelope protein, ampho-eco SU (16, 18), a modified SU first designed and characterized by Cosset and colleagues to study the problems encountered in targeting infection of retroviral gene therapy vectors (4). ampho-eco SU contains an insertion of the 208 amino acids of the amphotropic receptor binding domain between peptide linkers placed at residues 6 and 7 of MoMLV SU. In addition to having a postbinding defect (4), ampho-eco SU associates more weakly with TM than does wild-type ecotropic and amphotropic SU (18).The ability of the second-site mutations to suppress two different defects (i.e., a membrane fusion defect and a weak subunit association) suggested that they might act through more than one mechanism. It also raised the question of how much each mechanism contributed toward the rescue of infection by modified envelope proteins. Specifically, it was possible that they acted on ampho-eco SU only by stabilizing the subunit association. Here we demonstrate that the second-site mutations rescue infection by a modified SU of similar design to ampho-eco SU but having a strong subunit association. This third envelope protein mutant exhibits evidence of subtle misfoldi...